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Abstract
Background: Reactive lymphoid hyperplasia (RLH) of the liver is very rarely reported, and we
encountered two cases of RLH of the liver in a patient with colon cancer.
Case presentation: In the first case, a 77-year-old woman was admitted for the surgical removal
of a ascending colon cancer. A hepatic tumor in the left lobe was concurrently revealed by
computed tomography (CT), and magnetic resonance imaging (MRI). The appearance suggested
liver metastasis. Right hemicolectomy and partial hepatectomy were performed. On
histopathological examination, lymphoid follicles with germinal centers were seen in the tumor-like
lesion, and remarkable lymphoid infiltration with germinal centers was seen in the portal area
around the nodule. Immunohistochemical studies revealed polyclonality of infiltrating lymphocyte.
Consequently, this nodular lesion was diagnosed as RLH of the liver. In the second case, a 64-year-
old woman who had a radical right hemicolectomy for stage II ascending colon cancer 10 years ago
was admitted with dysuria. A hepatic tumor in the left lobe was concurrently revealed by CT and
MRI, suggesting hepatocellular carcinoma. A left lateral segmentectomy was performed.
Microscopically, this lesion revealed the almost same findings as the first case, so this nodular lesion
was diagnosed as RLH of the liver.
Conclusion: Our two cases were the first report of RLH of the liver accompanying colon cancer.
Because there are a very few cases, so it is not clear whether the malignancies were involved in the
onset of RLH. But we believe that new factors involved in the onset mechanism of RLH may be
identified by carefully monitoring the clinical course of our two patients.
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Background
Reactive lymphoid hyperplasia (RLH) is reported to occur
in the gastrointestinal tract [1], skin [2], lung [3], thyroid
[4], orbit [5], and pancreas [6]; however, it is very rarely
reported in the liver. To the best of our knowledge, only
12 cases with RLH of the liver have so far been reported in
the English literature [7-15]. RLH is thought to represent
an immune-mediated reactive phenomenon, and very few
cases may arise in association with malignant tumor. But,
there are no reports mentioned about the relationship
between RLH and malignant tumor. Our two cases were
the first report of RLH of the liver accompanying colon
cancer. So we report two cases of RLH of the liver accom-
panying colon cancer and discuss its morphological fea-
tures.
Case presentation
Case 1
A 77-year-old woman was admitted to our hospital with
right upper abdominal pain in December 2004. Barium
enema and colonoscopy revealed an ulcerative tumor in
the ascending colon, which was diagnosed as moderately
differentiated adenocarcinoma on biopsy. Physical exam-
ination showed no remarkable abnormalities. Neither
hepatomegaly nor splenomegaly were apparent. Serum
hepatitis B surface antigen and hepatitis C antibody were
negative, and she had no history of alcohol intake or
blood transfusion. Laboratory data on admission includ-
ing liver function tests were unremarkable. Carcinoem-
bryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-
9), and α-fetoprotein (AFP) were within normal ranges.
Abdominal ultrasonography showed a hypoechoic, 1.5-
cm diameter mass in the left hepatic lobe (S3). Computed
tomography (CT) revealed a low-density area in the same
area, the interior of which enhanced equally. The outline
of the mass was particularly enhanced in equilibrium
phase (Fig. 1). Magnetic resonance imaging (MRI) dem-
onstrated a slightly low-intensity lesion on T1-weighted
images; this was high-Intensity on T2-weighted images
(Fig. 2). Furthermore, superparamagnetic iron oxide
(SPIO) uptake was not detected on T2-weighted images.
Consequently, as metastatic liver tumor could not be
definitively excluded, the patient underwent right hemi-
colectomy and S3 partial hepatectomy on 1 November
2004.
An ulcerated tumor with sharply demarcation was present
in the ascending colon and histopathological examina-
tion revealed moderately differentiated adenocarcinoma.
No lymph node metastasis was detected. Macroscopically,
cut section of the resected liver showed a well-circum-
scribed, encapsulated, yellowish-white mass in S3 of the
liver. It measured 1.5 cm in diameter (Fig. 3). The tumor
appeared relatively soft and elastic and was composed of
many lymphoid follicles with large germinal centers con-
taining small polymorphic lymphocytes (Fig. 4). Many
plasma cells surrounded mature lymphoid aggregates.
Furthermore, remarkable lymphoid infiltration with ger-
minal center formation was seen in the portal area around
the nodule. However, the hepatic parenchyma distant
from this nodule was normal and lymphoid infiltration
was not detected in the portal area. No evidence of aden-
ocarcinoma metastasis and no cytologic atypia of the ger-
minal centers or interfollicular areas were detected.
Immunohistochemical studies revealed the germinal
centers to be composed of CD-20-positive and Bcl-2-neg-
ative lymphocytes. Furthermore, lymphocytes surround-
ing the germinal centers and interfollicular areas were
positive for CD-3 and Bcl-2. Plasma cells were positive for
both κ and λ light chains at an equal frequency (data not
shown). These findings revealed the polyclonal origins of
the infiltrating lymphocytes. Consequently, this nodular
a) Abdominal CT shows the 1.5-cm diameter low-density  mass in size in the S3 Figure 1
a) Abdominal CT shows the 1.5-cm diameter low-density 
mass in size in the S3. b) This lesion was slightly enhanced, 
and its periphery was noticeably enhanced on equilibrium 
phase.BMC Gastroenterology 2006, 6:25 http://www.biomedcentral.com/1471-230X/6/25
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lesion was diagnosed as RLH of the liver. No recurrence
has occurred during 20 months of postoperative follow
up.
Case 2
A 64-year-old woman who had a radical right hemicolec-
tomy for stage II ascending colon cancer 10 years ago was
admitted to our hospital with dysuria in July 2005. A
hepatic tumor in the left lobe of her liver was concurrently
revealed by CT scan. Serum hepatitis B surface antigen and
hepatitis C antibody were negative, and she had no his-
tory of alcohol intake or blood transfusion. Laboratory
data on admission including liver function tests were
unremarkable. CEA, CA19-9, and AFP were within normal
ranges. Abdominal ultrasonography showed a hypoe-
choic, 9 × 7 mm diameter mass in the left hepatic lobe
(S2). Plain CT examination revealed a low-density area,
the mass was enhanced by the contrast medium in early
phase. At a late phase, the mass was showed as a low-den-
sity area. MRI demonstrated a slightly low-intensity lesion
on T1-weighted images and a high-Intensity on T2-
weighted images. SPIO uptake was not detected on T2-
weighted images. At an early phase, Dynamic MRI
revealed low-intensity mass in S2 (Fig. 5a). At a late phase,
the mass was showed as a low-intensity area (Fig. 5b).
Consequently, this nodular lesion was diagnosed hepato-
cellular carcinoma rather than liver metastasis, the patient
was carried out left lateral segmentectomy on 7 September
2005.
Macroscopically, the resected liver had smooth surface
and a normal appearance, cut section of the resected liver
showed a well-circumscribed, not encapsulated, whitish
mass in S2 of the liver (Fig. 6). It measured 1.0 cm in
diameter. Microscopically, this lesion revealed the almost
same findings as Case 1, so this nodular lesion was diag-
nosed as RLH of the liver, too. No recurrence has occurred
during 10 months of postoperative follow up.
Discussion
Reactive lymphoid hyperplasia is recognized as a region
that is well demarcated and characterized by hyperplastic
lymphoid follicles with reactive germinal centers, which
consist of polymorphic and polyclonal cell populations
and aggregations of mature lymphocytes, plasma cells,
and other types of inflammatory cells [12]. In the liver,
these reactive lesions have been variously termed RLH,
nodular lymphoid lesions [14], and pseudolymphoma.
A cut section of the resected liver showed a well-circum- scribed, yellowish-white mass in S3 Figure 3
A cut section of the resected liver showed a well-circum-
scribed, yellowish-white mass in S3.
a) MRI showed a low-intensity lesion on the T1-weighted  image Figure 2
a) MRI showed a low-intensity lesion on the T1-weighted 
image. b) The border of the lesion was clearly visualized on 
the T2-weighted image with SPIO.BMC Gastroenterology 2006, 6:25 http://www.biomedcentral.com/1471-230X/6/25
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These lesions are very rare, and they appear clinically to
indicate the same disease. We decided to use the term
"RLH of the liver" because this most closely reflects the
pathological features of the disease. However, the term
"pseudolymphoma" is problematic because it indicates a
low-grade type of MALT lymphoma. Since malignant
transformation is reported in this type of MALT lym-
phoma, surgical resection is indicated. Therefore, even
when pseudolymphoma is diagnosed preoperatively,
some patients have undergone resective surgery [13]. In
contrast, as RLH is not considered to have malignant
potential, therapeutic strategies are totally different from
those for low-grade MALT-type lymphoma. We therefore
believe it is necessary to eliminate the ambiguous term
"pseudolymphoma" and clearly differentiate RLH from
low-grade MALT-type lymphoma. Some past studies have
also advocated this approach to classification, and Sharifi
Dynamic MRI Figure 5
Dynamic MRI. a) Plain MRI showed the 1.0-cm diameter low-
intensity mass in size in the S2. b) This nodular lesion was 
enhanced at an early phase. c) At a late phase, this lesion was 
showed as low-intensity mass than surrounding liver tissue.
Many lymphoid follicles with germinal centers were seen in  the tumor-like hepatic lesion (a: ×40, b: ×400), HE staining Figure 4
Many lymphoid follicles with germinal centers were seen in 
the tumor-like hepatic lesion (a: ×40, b: ×400), HE staining.
A cut section of the resected liver showed a well-circum- scribed, whitish mass in S2 Figure 6
A cut section of the resected liver showed a well-circum-
scribed, whitish mass in S2.B
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Table 1: Reported cases of reactive lymphoid hyperplasia of the liver.
No. age sex segment Size(cm) CT MRI US Angio association Author/Year
1 69 F Rt post lobe 1.7*1.0*0.9 plain: low
not enhanced
- - - 7 yeas after RCC ope. Pantanowitz/2001
2 47 F S7 1.7 plain: low
enhanced
T1- low
T2-high
hypoechoic
hyperechoic rim
hypervascular Hashimoto's thyroiditis Nagano/1999
3 67 F Lt lobe 2 plain: low
sl. enhanced
- hypoechoic hypervascular - Tanizawa/1996
4 52 F Rt lobe 0.4 - - - - primaly biliary cirrhousis Sharifi/1999
5 56 F Lt lobe 1.5 - - - - primaly biliary cirrhousis
CREST synd.
Sharifi/1999
6 56 M - 0.7 - - - - chronic diverticular Sharifi/1999
7 15 F - - - - - - primary immunodeficiency synd. Snover/1981
8 49 F Rt post lobe 2 Tumor lesion (+) T1-low
T2-high
tumor lesion (+) hypervascular Sjögren's synd. Okubo/2001
9 42 F S6, S3 S3:1.1
S6:1.6
low density
Enhance-CT:iso
- hypoechoic tumor stain(+) chronic hepatitis B, IFN-α Ohtsu/1994
10 72 M S3 2.1*1.4 Plain: no tumor
Early: high, late: iso-low
T1-low
T2-high
hypoechoic failure chronic hepatitis C
early gastric cancer
Kim/1997
11 66 F Rt lobe 1.0*1.0 plain: low
not enhanced
- hypoechoic tumor stain(+) DM Katayanagi/1994
12 85 F Rt lobe 1.4*0.8*1.0
0.7*0.8*0.7
- - - - gastric cancer Grouls/1984
Our cases
1 77 F S3 1.5 plain: low, enhance sl.(+) T1-low
T2-high
hypoechoic - colon cancer
2 64 F S2 0.9*0.7 Plain: low, enhance-CT
Early:high, late:low
T1-low
T2-high
hypoechoic tumor stain(-) 10 years after colon cancerBMC Gastroenterology 2006, 6:25 http://www.biomedcentral.com/1471-230X/6/25
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and colleagues [14] have proposed clear diagnostic crite-
ria. Immunohistological and genetic tests to ascertain
whether infiltrating lymphocytes are monoclonal or poly-
clonal enable differentiation of RLH from low-grade
MALT-type lymphoma.
By previously reported cases, in terms of imaging findings,
RLH of the liver is depicted as a hypoechoic lesion on
ultrasound and as a low-density lesion on plain CT, but
contrast CT findings vary. Both MRI T1-low and T2-high
intensity images yield the same results, and angiography
shows hypervascularity. In our patients, results of preop-
erative diagnostic imaging conformed to this pattern; i.e.
low-echo and plain CT demonstrated a low-density
lesion, while contrast CT showed mild enhancement.
Moreover, on equilibrium phase of contrast CT in the first
patient, the area around RLH was depicted as a high-den-
sity area, possibly indicating a capsule. The present study
was the first to conduct contrast SPIO-enhanced MRI in
hepatic RLH. No SPIO uptake into the mass occurred, and
the boundary with the normal liver was very clear. The fur-
ther discussion of such rare cases based on the imaging
findings including SPIO-enhanced MRI will provide more
information about this rare entity. But, at this point in
time, it is very difficult to completely rule out malignan-
cies such as HCC, metastatic liver tumors, or malignant
lymphomas based solely on diagnostic imaging findings.
Ultimately, preoperative biopsy is therefore an essential
diagnostic tool.
While the cause of RLH has not been clarified, most
patients are middle-aged or elderly women. In terms of
underlying diseases, various chronic inflammatory dis-
eases, such as chronic hepatitis, Sjogren's syndrome,
chronic thyroiditis, and primary biliary cirrhosis, have
been confirmed. Hence, autoimmune mechanisms are
most likely involved. In our cases, the patients were a mid-
dle-aged woman and lymphoid infiltration was observed
in the portal area around the nodule, suggesting a similar
mechanism. However, lymphoid infiltration was con-
fined to the area around the nodule, the rest of the hepatic
parenchyma was normal, and hepatitis virus markers were
negative, suggesting that this lesion was local rather than
diffuse. Furthermore, as systemic immunologic abnor-
malities were not detected, our cases did not appear to be
associated with systemic autoimmune disease. Including
the present patients, five cases of hepatic RLH accompany-
ing malignancies have been reported [8,11,15], some of
which had asynchronous onset, but the present study is
the first to report RLH of the liver accompanying colon
cancer. Because there are a very few cases, so it is not clear
whether the malignancies were involved in the onset of
RLH. Furthermore, characteristic imaging findings or
morphological features in these patients were not
detected. But we believe that new factors involved in the
onset mechanism of RLH may be identified by carefully
monitoring the clinical course of our two patients.
Conclusion
In summary, we report two cases of RLH of the liver in a
patient with colon cancer. RLH of the liver is extremely
rare and it is very difficult to think of RLH of the liver as
differential diagnosis.
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